Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Now Rated “Moderate Buy” by Wall Street Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been given a consensus rating of “Moderate Buy” by the twelve brokerages that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $14.06.

A number of research analysts have recently issued reports on AVAH shares. UBS Group raised their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Royal Bank Of Canada increased their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research note on Monday, August 24th. Wall Street Zen cut shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. JPMorgan Chase & Co. lifted their target price on Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a research note on Monday, September 14th. Finally, BMO Capital Markets upped their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th.

Insiders Place Their Bets

In related news, insider Edwin Reisz sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $575,000.00. Following the completion of the transaction, the insider owned 1,397,897 shares in the company, valued at $16,075,815.50. The trade was a 3.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the transaction, the insider owned 12,315,892 shares of the company’s stock, valued at $141,632,758. This represents a 15.45% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 48,566,081 shares of company stock worth $558,509,932. 5.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently made changes to their positions in the company. Farther Finance Advisors LLC boosted its position in shares of Aveanna Healthcare by 217.1% during the third quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock worth $37,000 after buying an additional 2,039 shares during the period. Caitong International Asset Management Co. Ltd grew its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares in the last quarter. GK Wealth Management LLC acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at approximately $90,000. C M Bidwell & Associates Ltd. acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $69,000. Finally, Summit Securities Group LLC bought a new stake in Aveanna Healthcare during the 1st quarter valued at $53,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Trading Up 0.8%

NASDAQ:AVAH opened at $12.44 on Tuesday. The company has a market cap of $2.71 billion, a PE ratio of 10.11, a P/E/G ratio of 0.76 and a beta of 1.95. The business’s 50 day moving average is $12.88 and its two-hundred day moving average is $9.61. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a 52 week low of $5.93 and a 52 week high of $14.71.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. On average, analysts predict that Aveanna Healthcare will post 0.77 EPS for the current year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna’s services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.